← Back to Screener
Enovis Corporation (ENOV)
Price$26.27
Favorite Metrics
Price vs S&P 500 (26W)-20.10%
Price vs S&P 500 (4W)10.96%
Market Capitalization$1.52B
All Metrics
P/CF (Annual)6.99x
Book Value / Share (Quarterly)$26.05
P/TBV (Annual)6.02x
Revenue Growth (3Y)12.88%
Cash Flow / Share (Quarterly)$0.35
Price vs S&P 500 (YTD)-5.34%
Gross Margin (TTM)58.16%
Net Profit Margin (TTM)-52.69%
EPS (TTM)$-20.72
10-Day Avg Trading Volume0.73M
EPS Excl Extra (TTM)$-20.72
Revenue Growth (5Y)-6.05%
EPS (Annual)$-20.75
ROI (Annual)-42.51%
Gross Margin (Annual)58.16%
Net Profit Margin (5Y Avg)-17.93%
Cash / Share (Quarterly)$0.64
Revenue Growth QoQ (YoY)2.64%
ROA (Last FY)-30.89%
Revenue Growth TTM (YoY)6.66%
EBITD / Share (TTM)$-16.66
ROE (5Y Avg)-22.31%
Operating Margin (TTM)-50.09%
Cash Flow / Share (Annual)$0.35
P/B Ratio1.02x
P/B Ratio (Quarterly)1.02x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.24x
Net Interest Coverage (TTM)-32.29x
ROA (TTM)-26.08%
EV / EBITDA (TTM)39.32x
EPS Incl Extra (Annual)$-20.75
Current Ratio (Annual)2.02x
Quick Ratio (Quarterly)0.97x
3-Month Avg Trading Volume1.00M
52-Week Price Return-15.53%
EV / Free Cash Flow (Annual)139.49x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$4.42
P/S Ratio (Annual)0.68x
Asset Turnover (Annual)0.59x
52-Week High$37.85
Operating Margin (5Y Avg)-20.71%
EPS Excl Extra (Annual)$-20.75
CapEx CAGR (5Y)11.45%
26-Week Price Return-11.35%
Quick Ratio (Annual)0.97x
13-Week Price Return8.45%
Total Debt / Equity (Annual)0.87x
Current Ratio (Quarterly)2.02x
Enterprise Value$2,778.303
Revenue / Share Growth (5Y)-9.89%
Asset Turnover (TTM)0.49x
Book Value / Share Growth (5Y)-5.69%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.66x
Pretax Margin (Annual)-51.57%
Cash / Share (Annual)$0.64
3-Month Return Std Dev51.71%
Gross Margin (5Y Avg)56.70%
Net Income / Employee (TTM)$-0
EBITDA Interim CAGR (5Y)-8.47%
ROE (Last FY)-79.51%
Net Interest Coverage (Annual)-32.29x
EPS Basic Excl Extra (Annual)$-20.75
P/FCF (TTM)23.43x
Receivables Turnover (TTM)5.29x
EV / Free Cash Flow (TTM)139.49x
Total Debt / Equity (Quarterly)0.87x
EPS Incl Extra (TTM)$-20.72
Receivables Turnover (Annual)5.29x
ROI (TTM)-33.50%
P/S Ratio (TTM)0.68x
Pretax Margin (5Y Avg)-20.64%
Revenue / Share (Annual)$39.39
Tangible BV / Share (Annual)$4.42
Forward P/E7.33x
Free OCF CAGR (5Y)-36.11%
Price vs S&P 500 (52W)-50.63%
Year-to-Date Return-1.20%
5-Day Price Return5.87%
EPS Normalized (Annual)$-20.75
ROA (5Y Avg)-9.72%
Net Profit Margin (Annual)-52.69%
Month-to-Date Return15.69%
Cash Flow / Share (TTM)$1.86
EBITD / Share (Annual)$-13.43
Operating Margin (Annual)-50.09%
LT Debt / Equity (Annual)0.85x
P/CF (TTM)6.99x
ROI (5Y Avg)-12.77%
LT Debt / Equity (Quarterly)0.85x
EPS Basic Excl Extra (TTM)$-20.72
P/TBV (Quarterly)6.02x
P/B Ratio (Annual)1.02x
Inventory Turnover (TTM)1.66x
Pretax Margin (TTM)-51.57%
Book Value / Share (Annual)$26.05
Price vs S&P 500 (13W)5.58%
Beta1.63x
P/FCF (Annual)76.21x
Revenue / Share (TTM)$39.31
ROE (TTM)-54.42%
52-Week Low$21.00
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.18
4.22
4.22
4.22
Industry Peers — Orthopedic & Prosthetic Devices(25)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ENOVEnovis Corporation | 0.68x | -6.05% | 58.16% | -50.09% | $26.27 |
ISRGIntuitive Surgical Inc. | 16.54x | 18.22% | 66.00% | 29.27% | $465.60 |
EWEdwards Lifesciences Corp | 7.77x | 6.70% | 78.01% | 18.41% | $81.44 |
STESTERIS plc | 3.81x | 12.49% | 44.11% | 17.03% | $226.41 |
ZBHZimmer Biomet Holdings, Inc. | 2.31x | 3.22% | 69.71% | 13.34% | $95.48 |
ALGNAlign Technology Inc | 3.41x | 10.30% | 68.27% | 13.53% | $191.66 |
SNNSmith & Nephew plc | 2.37x | 6.21% | 68.01% | 12.88% | $34.21 |
MSAMine Safety Incorporated | 3.60x | 6.82% | 46.46% | 19.83% | $173.50 |
ESTAEstablishment Labs Holdings Inc. | 9.30x | 20.04% | 69.32% | -18.48% | $66.93 |
CDRECadre Holdings, Inc. | 2.19x | 8.57% | 42.54% | 11.04% | $30.51 |
AVNSAvanos Medical, Inc. | 1.64x | -0.38% | 50.47% | -8.78% | $24.64 |
About
Enovis manufactures orthopedic and rehabilitation devices for reconstructive surgery, injury prevention, and pain management. The company serves orthopedic specialists, primary care physicians, physical therapists, and athletic trainers, addressing musculoskeletal conditions ranging from sports injuries and deformities to degenerative diseases. Its Prevention & Recovery segment, which represents the majority of revenue, provides post-surgical rehabilitation and chronic condition management solutions.